Can a patient be given 30 units of insulin glargine (Lantus) at bedtime?

Yes, Lantus 30 units at bedtime is an appropriate and FDA-approved dosing regimen.

Lantus (insulin glargine) can be safely administered at bedtime, and 30 units falls within the typical dosing range used in clinical practice. The FDA label explicitly states that Lantus was administered at bedtime in multiple clinical trials for both type 1 and type 2 diabetes, demonstrating efficacy and safety 1.

Dosing Considerations

Starting Dose vs. Maintenance Dose

The 2025 ADA guidelines recommend starting basal insulin at 10 units per day OR 0.1-0.2 units/kg per day for insulin-naive patients 2. However, 30 units represents a reasonable maintenance dose after titration, particularly for:

• Patients already on insulin therapy
• Those with higher insulin requirements
• Individuals transitioning from NPH insulin (where the FDA label suggests using 80% of the previous NPH dose when switching to Lantus) 1

Timing Flexibility

While bedtime administration is the most studied and traditional approach, the evidence shows:

• Bedtime dosing is associated with better fasting glucose control but carries a higher risk of nocturnal hypoglycemia compared to morning dosing 3, 4, 5
• Morning administration is equally effective for overall glycemic control with lower nocturnal hypoglycemia risk 6, 5
• The FDA label confirms Lantus can be given at breakfast, dinner, or bedtime with similar HbA1c reductions 1

Key Safety Points

Monitor for nocturnal hypoglycemia when using bedtime dosing. Studies consistently show:

• Bedtime glargine increases nocturnal hypoglycemia events compared to morning dosing 3, 4
• The risk is particularly elevated between midnight and 4:00 AM 4
• If nocturnal hypoglycemia occurs without clear cause, reduce the dose by 10-20% 2

Titration Algorithm

Following the 2025 ADA guidelines 2:

• Set a fasting plasma glucose goal
• Increase by 2 units every 3 days to reach target without hypoglycemia
• For hypoglycemia without clear cause: reduce dose by 10-20%
• Assess adequacy at every visit

Clinical Pitfalls to Avoid

1. Don't assume 30 units is appropriate for all patients - this dose should be individualized based on current insulin requirements, body weight, and glycemic control
2. Watch for overbasalization - if bedtime-to-morning glucose differential is elevated or postprandial excursions are significant, consider adding prandial insulin or GLP-1 RA rather than increasing basal dose 2
3. Consider morning dosing if the patient experiences recurrent nocturnal hypoglycemia 6, 5